Mode
Text Size
Log in / Sign up

Chronic Lung Disease

5 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Chronic Lung Disease

8 trials tracked for Chronic Lung Disease: 1 in phase 3 or 4.

8Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 2 1 Other / NA 6
  1. Phase 4 Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis) Completed
  2. Phase 2 Antibiotic "Dysbiosis" in Preterm Infants Completed
  3. N/A BPD Saturation TARgeting Completed
  4. N/A MoveStrong at Home: A Feasibility Study of a Model for Remote Delivery of Functional Strength and Balance Training Combined With Nutrition Education for Older Pre-frail Adults. Completed
  5. N/A Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors Completed
  6. N/A Project to Improve Communication About Serious Illness - Pilot Study Completed
Show 2 more trials
  1. N/A The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung Disease Completed
  2. N/A Functional Exercise and Nutrition Education Program for Older Adults Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Chronic Lung Disease

What underlying health conditions increase the risk of severe COVID-19 in chronic lung disease?

People with chronic lung disease face higher risks of severe COVID-19 if they also have conditions like diabetes, heart disease, or smoking history.

Full answer →